- Home
- LXRX vs NXJ Comparison
LXRX vs NXJ Comparison
Compare LXRX & NXJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- NXJ
- Stock Information
- Founded
- LXRX 1995
- NXJ 1999
- Country
- LXRX United States
- NXJ United States
- Employees
- LXRX N/A
- NXJ N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- NXJ Finance/Investors Services
- Sector
- LXRX Health Care
- NXJ Finance
- Exchange
- LXRX Nasdaq
- NXJ Nasdaq
- Market Cap
- LXRX 428.8M
- NXJ 457.7M
- IPO Year
- LXRX 2000
- NXJ N/A
- Fundamental
- Price
- LXRX $1.19
- NXJ $11.29
- Analyst Decision
- LXRX Buy
- NXJ
- Analyst Count
- LXRX 5
- NXJ 0
- Target Price
- LXRX $3.23
- NXJ N/A
- AVG Volume (30 Days)
- LXRX 2.4M
- NXJ 74.9K
- Earning Date
- LXRX 08-06-2025
- NXJ 01-01-0001
- Dividend Yield
- LXRX N/A
- NXJ 3.27%
- EPS Growth
- LXRX N/A
- NXJ N/A
- EPS
- LXRX N/A
- NXJ N/A
- Revenue
- LXRX $58,432,000.00
- NXJ N/A
- Revenue This Year
- LXRX N/A
- NXJ N/A
- Revenue Next Year
- LXRX N/A
- NXJ N/A
- P/E Ratio
- LXRX N/A
- NXJ N/A
- Revenue Growth
- LXRX 1504.83
- NXJ N/A
- 52 Week Low
- LXRX $0.28
- NXJ $10.06
- 52 Week High
- LXRX $2.18
- NXJ $12.24
- Technical
- Relative Strength Index (RSI)
- LXRX 56.85
- NXJ 49.30
- Support Level
- LXRX $1.12
- NXJ $11.12
- Resistance Level
- LXRX $1.27
- NXJ $11.52
- Average True Range (ATR)
- LXRX 0.09
- NXJ 0.09
- MACD
- LXRX -0.00
- NXJ -0.01
- Stochastic Oscillator
- LXRX 68.00
- NXJ 42.50
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.